Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC)
Clinical trial NCT07545083 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07545083
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.